← FDA Drug Approvals (Drugs@FDA)
POSACONAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-11-30
Drug application
- FDA Application #
ANDA207355- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POSACONAZOLE
- Generic name
- Posaconazole
- Active ingredients
- POSACONAZOLE
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS LABS FL INC
- First approval
- 2022-11-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown